Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Related Citations for PubMed (Select 23616046)

1.

Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.

Fu Y, Lai Y, Wang Q, Liu X, He W, Zhang H, Fan C, Yang G.

Mol Med Rep. 2013 Jun;7(6):1726-32. doi: 10.3892/mmr.2013.1436. Epub 2013 Apr 23.

PMID:
23616046
2.

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.

Hassan MK, Watari H, Han Y, Mitamura T, Hosaka M, Wang L, Tanaka S, Sakuragi N.

J Exp Clin Cancer Res. 2011 Dec 20;30:113. doi: 10.1186/1756-9966-30-113.

3.

Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.

Inan S, Vatansever S, Celik-Ozenci C, Sanci M, Dicle N, Demir R.

Histol Histopathol. 2006 Oct;21(10):1055-64.

PMID:
16835828
4.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

5.

Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.

Yang G, Zhang H, Liu Y, Zhou J, He W, Quick CM, Xie D, Smoller BR, Fan CY.

Arch Gynecol Obstet. 2013 May;287(5):989-95. doi: 10.1007/s00404-012-2650-6. Epub 2012 Dec 4.

PMID:
23208459
6.

Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.

Wei L, Xue T, Wang J, Chen B, Lei Y, Huang Y, Wang H, Xin X.

Int J Cancer. 2009 Aug 15;125(4):791-806. doi: 10.1002/ijc.24316.

PMID:
19391138
7.

Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.

Szubert S, Szpurek D, Moszynski R, Nowicki M, Frankowski A, Sajdak S, Michalak S.

J Cancer Res Clin Oncol. 2014 Mar;140(3):361-9. doi: 10.1007/s00432-013-1569-z. Epub 2013 Dec 28.

8.

Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.

Semaan A, Munkarah AR, Arabi H, Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT, Ali-Fehmi R.

Gynecol Oncol. 2011 Apr;121(1):181-6. doi: 10.1016/j.ygyno.2010.11.019. Epub 2010 Dec 16.

PMID:
21167567
9.

Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.

Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.

Pathol Res Pract. 2008;204(6):379-87. doi: 10.1016/j.prp.2008.01.011. Epub 2008 Mar 17.

PMID:
18343598
10.
11.

Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.

Hata K, Fujiwaki R, Nakayama K, Maede Y, Fukumoto M, Miyazaki K.

Anticancer Res. 2000 Sep-Oct;20(5C):3941-9.

PMID:
11268481
12.

[Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].

Luo J, Peng ZL, Yang KX, Wang H, Yang H, Dong DD, Yao XY.

Zhonghua Fu Chan Ke Za Zhi. 2005 Jan;40(1):38-41. Chinese.

PMID:
15774091
13.

Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer.

Siddiqui GK, Elmasry K, Wong Te Fong AC, Perrett C, Morris R, Crow JC, Maclean AB.

Eur J Gynaecol Oncol. 2010;31(2):156-9.

PMID:
20527230
14.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.

Oncol Rep. 2003 Jan-Feb;10(1):89-95.

PMID:
12469150
15.

Overexpression of clusterin in ovarian cancer is correlated with impaired survival.

Yang GF, Li XM, Xie D.

Int J Gynecol Cancer. 2009 Nov;19(8):1342-6. doi: 10.1111/IGC.0b013e3181a83ed9.

PMID:
20009887
16.

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I.

Clin Exp Metastasis. 2002;19(2):135-44.

PMID:
11964077
17.

Clusterin plays an important role in hepatocellular carcinoma metastasis.

Lau SH, Sham JS, Xie D, Tzang CH, Tang D, Ma N, Hu L, Wang Y, Wen JM, Xiao G, Zhang WM, Lau GK, Yang M, Guan XY.

Oncogene. 2006 Feb 23;25(8):1242-50.

PMID:
16247463
18.

The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.

Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T.

Int J Gynecol Pathol. 1997 Jul;16(3):256-62.

PMID:
9421092
19.

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK.

J Natl Cancer Inst. 1995 Apr 5;87(7):506-16.

PMID:
7707437
20.

Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.

Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.

Int J Gynecol Pathol. 2011 May;30(3):205-17. doi: 10.1097/PGP.0b013e3182063e71.

PMID:
21464733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk